Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Quick Stats
Jan 30, 202664.4
AI Score
BUY1.34
Volume Ratio
Feb 17, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
HALO Stock Summary
Last updated Jan 30, 2026
HALO is currently trading at $71.71, positioned above its 200-day moving average of $64.59, indicating a long-term uptrend. The stock has a 52-week range of $47.5 to $79.5.
Technical Analysis: The 50-day moving average stands at $68.98, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 53.947, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.172, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates HALO at 64.4/100 with a BUY recommendation.
HALO (Halozyme Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 53.947 |
| CMF (20) | 0.172 |
| ROC (10) | -0.153 |
| ADX (14) | 28.622 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.846 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -49.201 |
| MFI (14) | 48.118 |
HALO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
HALO Price vs Max Options Open Interest
HALO Max Change In Options Open Interest
HALO Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HALO Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HALO Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HALO Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Halozyme Therapeutics, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
HALO Moving Averages Analysis
Halozyme Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Halozyme Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
HALO (Halozyme Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 71.22 |
| 20 | 71.77 |
| 30 | 70.4 |
| 50 | 68.98 |
| 100 | 69.57 |
| 200 | 64.59 |
HALO Fundamental Analysis
| P/E (Forward) | 8.5985 |
| P/E (Trailing) | 15.1287 |
| Market Cap ($) | 8.4 billion |
| Earnings/Share ($) | 4.74 |
| Net Proft Margin (%) | 0.4791 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 6.48 |
| EPS Estimate Next Year ($) | 8.2125 |
| WallStreet Target Price ($) | 78 |
| Most Recent Quarter |